The risk of invasive pneumococcal disease differs between risk groups in Norway following widespread use of the 13-valent pneumococcal vaccine in children
dc.contributor.author | Winje, Brita Askeland | |
dc.contributor.author | Vestrheim, Didrik Frimann | |
dc.contributor.author | White, Richard Aubrey | |
dc.contributor.author | Steens, Anneke | |
dc.date.accessioned | 2021-12-03T07:21:09Z | |
dc.date.available | 2021-12-03T07:21:09Z | |
dc.date.created | 2021-09-28T16:21:44Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Microorganisms. 2021, 9 (8), 1-14. | |
dc.identifier.issn | 2076-2607 | |
dc.identifier.uri | https://hdl.handle.net/11250/2832662 | |
dc.language.iso | eng | |
dc.title | The risk of invasive pneumococcal disease differs between risk groups in Norway following widespread use of the 13-valent pneumococcal vaccine in children | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1-14 | |
dc.source.volume | 9 | |
dc.source.journal | Microorganisms | |
dc.source.issue | 8 | |
dc.identifier.doi | 10.3390/microorganisms9081774 | |
dc.identifier.cristin | 1940021 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 |
Files in this item
This item appears in the following Collection(s)
-
Artikler [5061]
-
Publikasjoner fra CRIStin FHI [7531]